Suppr超能文献

6-烷基氨基-N-苯基吡嗪-2-甲酰胺的合成与抗菌活性评价

Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.

作者信息

Servusova-Vanaskova Barbora, Paterova Pavla, Garaj Vladimir, Mandikova Jana, Kunes Jiri, Naesens Lieve, Jílek Petr, Dolezal Martin, Zitko Jan

机构信息

Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic.

Department of Clinical Microbiology, University Hospital Hradec Králové, Sokolská 581, Hradec Králové, 500 05, Czech Republic.

出版信息

Chem Biol Drug Des. 2015 Oct;86(4):674-81. doi: 10.1111/cbdd.12536. Epub 2015 Mar 6.

Abstract

This work presents synthesis and antimicrobial evaluation of nineteen 6-alkylamino-N-phenylpyrazine-2-carboxamides. Antimycobacterial activity was determined against Mycobacterium tuberculosis H37Rv, M. kansasii and two strains of M. avium. Generally, the antimycobacterial activity increased with prolongation of simple alkyl chain and culminated in compounds with heptylamino substitution (3e, 4e) with MIC = 5-10 μm against M. tuberculosis H37Rv. On the contrary, derivatives with modified alkyl chain (containing e.g. terminal methoxy or hydroxy group) as well as phenylalkylamino derivatives were mainly inactive. The most active compounds (with hexyl to octylamino substitution) were evaluated for their in vitro activity against drug-resistant strains of M. tuberculosis and possessed activity comparable to that of the reference drug isoniazid. None of the tested compounds were active against M. avium. Some derivatives exhibited activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (best MIC = 7.8 μm), while Gram-negative strains as well as tested fungal strains were completely unsusceptible. Active compounds were tested for in vitro toxicity on various cell lines and in most cases were non-toxic up to 100 μm.

摘要

本研究介绍了19种6-烷基氨基-N-苯基吡嗪-2-甲酰胺的合成及抗菌活性评估。测定了其对结核分枝杆菌H37Rv、堪萨斯分枝杆菌和两株鸟分枝杆菌的抗分枝杆菌活性。一般来说,抗分枝杆菌活性随着简单烷基链的延长而增强,在庚基氨基取代的化合物(3e、4e)中达到最高,对结核分枝杆菌H37Rv的最低抑菌浓度(MIC)=5-10μm。相反,具有修饰烷基链(如含有末端甲氧基或羟基)的衍生物以及苯基烷基氨基衍生物大多无活性。对活性最高的化合物(己基至辛基氨基取代)进行了对结核分枝杆菌耐药菌株的体外活性评估,其活性与参考药物异烟肼相当。所有测试化合物对鸟分枝杆菌均无活性。一些衍生物对革兰氏阳性菌有活性,包括耐甲氧西林金黄色葡萄球菌(最佳MIC=7.8μm),而革兰氏阴性菌和测试的真菌菌株则完全不敏感。对活性化合物进行了各种细胞系的体外毒性测试,在大多数情况下,浓度高达100μm时均无毒。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验